Pharma / Biotech

FDA Approves Imbruvica With Gazyva for First-Line CLL Treatment



The FDA expanded the labeling for Imbruvicato include use with Gazyva in treatment-naive patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

 

Source link




Related posts

BUPROPION HYDROCHLORIDE Tablet, Film Coated [Cardinal Health]

Newsemia

LEVOFLOXACIN Tablet [NuCare Pharmaceuticals,Inc.]

Newsemia

Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy